Table 2.

Characteristics of HES patients with increased and normal tryptase levels


Patient group

Serum tryptase level 11.5 ng/mL or greater

Serum tryptase level less than 11.5 ng/mL

P
Number of patients   9   6   
Median age, y (range)   38 (28-77)   36 (17-57)   NS  
Sex, M/F   9/0   1/5   < .01  
WBC, × 109/L, median (range)   18.1 (13.3-31.6)   8.2 (6.2-16.4)   .04  
Eosinophils, × 109/L, median (range)   8.352 (2.425-27.550)   1.792 (.707-6.216)   < .01  
Basophils, × 109/L, median (range)   .001 (0-.072)   .026 (.009-.057)   NS  
Splenomegaly   7/9   0/6   < .01  
Myeloid precursors on peripheral smear   8/9   0/6   < .01  
Bone marrow biopsy cellularity, greater than 50%   7/9   1/4   NS  
Dysplastic mast cells*  7/9   0/4   .02  
Myelofibrosis  5/9   0/4   NS  
Median hemoglobin, g/dL (range)   12.2 (6.9-13.8)   13.8 (11-15)   .08  
Median platelet count, 109/L (range)   165 (95-223)   283 (192-531)   < .01  
Median serum IgE level, kU/L (range)   15 (0-4862)   137 (11-544)   .08  
Median serum B12 level, pM (range)
 
4255 (2315-20 316)
 
592 (276-838)
 
< .01
 

Patient group

Serum tryptase level 11.5 ng/mL or greater

Serum tryptase level less than 11.5 ng/mL

P
Number of patients   9   6   
Median age, y (range)   38 (28-77)   36 (17-57)   NS  
Sex, M/F   9/0   1/5   < .01  
WBC, × 109/L, median (range)   18.1 (13.3-31.6)   8.2 (6.2-16.4)   .04  
Eosinophils, × 109/L, median (range)   8.352 (2.425-27.550)   1.792 (.707-6.216)   < .01  
Basophils, × 109/L, median (range)   .001 (0-.072)   .026 (.009-.057)   NS  
Splenomegaly   7/9   0/6   < .01  
Myeloid precursors on peripheral smear   8/9   0/6   < .01  
Bone marrow biopsy cellularity, greater than 50%   7/9   1/4   NS  
Dysplastic mast cells*  7/9   0/4   .02  
Myelofibrosis  5/9   0/4   NS  
Median hemoglobin, g/dL (range)   12.2 (6.9-13.8)   13.8 (11-15)   .08  
Median platelet count, 109/L (range)   165 (95-223)   283 (192-531)   < .01  
Median serum IgE level, kU/L (range)   15 (0-4862)   137 (11-544)   .08  
Median serum B12 level, pM (range)
 
4255 (2315-20 316)
 
592 (276-838)
 
< .01
 

NS indicates not significant.

*

More than 25% of mast cells in bone marrow biopsy are spindle-shaped.

Presence of antireticulin antibody staining on bone marrow biopsy.

Close Modal

or Create an Account

Close Modal
Close Modal